(Q44314486)

1 December 2017

title

Treatment of severe esophageal Crohn's disease with infliximab (English)

1 reference

1 December 2017

1 reference

Heller T

1

1 reference

1 December 2017

James SP

2

1 reference

1 December 2017

Drachenberg C

3

1 reference

1 December 2017

Hernandez C

4

1 reference

1 December 2017

Darwin PE

5

1 reference

1 December 2017

publication date

1 November 1999

1 reference

Inflammatory Bowel Diseases

1 December 2017

published in

1 reference

1 December 2017

volume

5

1 reference

1 December 2017

issue

4

1 reference

1 December 2017

page(s)

279-282

1 reference

Cervical Crohn's disease with oesophago-pulmonary fistula

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199911000-00006

Crossref

reference URL

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199911000-00006

Crossref

reference URL

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-199911000-00006

Crossref

reference URL

10.1097/00054725-199911000-00006

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference